We are live on ! Find out more
PCM

Palouse Capital Management Portfolio holdings

AUM $160M
1-Year Est. Return 36.15%
This Fund
S&P 500
This Quarter Est. Return
+1.98%
1 Year Est. Return
+36.15%
3 Year Est. Return
+67.75%
5 Year Est. Return
+68.17%
10 Year Est. Return
+160.38%
AUM
$179M
AUM Growth
-$10.8M
Cap. Flow
-$13.9M
Cap. Flow %
-7.78%
Top 10 Hldgs %
28.41%
Holding
86
New
13
Increased
11
Reduced
50
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 22.18%
2 Technology 16.22%
3 Financials 12.03%
4 Consumer Staples 11.2%
5 Consumer Discretionary 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
1
AbbVie
ABBV
$433B
$6.63M 3.71%
75,712
-15,081
-17% -$1.42M
VCSH icon
2
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.6B
$6.21M 3.48%
+75,017
New +$6.22M
GILD icon
3
Gilead Sciences
GILD
$163B
$5.49M 3.07%
86,806
+8,315
+11% +$577K
AMGN icon
4
Amgen
AMGN
$204B
$4.8M 2.69%
18,879
-4,192
-18% -$1.04M
PPL
5
PPL Corp
PPL
$26.5B
$4.78M 2.68%
175,722
-29,581
-14% -$798K
ADM icon
6
Archer Daniels Midland
ADM
$37.6B
$4.71M 2.64%
101,393
-25,963
-20% -$1.14M
TAP icon
7
Molson Coors Class B
TAP
$7.86B
$4.65M 2.61%
138,636
+29,766
+27% +$1.07M
IPG
8
DELISTED
Interpublic Group of Companies
IPG
$4.5M 2.52%
269,830
-48,845
-15% -$871K
JNJ icon
9
Johnson & Johnson
JNJ
$613B
$4.49M 2.51%
30,147
-5,533
-16% -$819K
PRU icon
10
Prudential Financial
PRU
$42.7B
$4.45M 2.49%
70,074
-10,825
-13% -$712K
GD icon
11
General Dynamics
GD
$103B
$4.42M 2.48%
31,921
+532
+2% +$78.6K
TSN icon
12
Tyson Foods
TSN
$21B
$4.36M 2.44%
73,246
-12,200
-14% -$752K
BMY icon
13
Bristol-Myers Squibb
BMY
$134B
$4.35M 2.43%
72,078
-15,531
-18% -$935K
PFF icon
14
iShares Preferred and Income Securities ETF
PFF
$13.3B
$4.32M 2.42%
118,614
-27,551
-19% -$991K
SJM icon
15
J.M. Smucker
SJM
$12.6B
$4.2M 2.35%
+36,375
New +$4.05M
IP icon
16
International Paper
IP
$21.9B
$4.16M 2.33%
108,471
-19,189
-15% -$677K
HBAN icon
17
Huntington Bancshares
HBAN
$35.1B
$4.15M 2.33%
452,993
-77,400
-15% -$721K
INTC icon
18
Intel
INTC
$459B
$4.08M 2.29%
+78,875
New +$4.1M
WBA
19
DELISTED
Walgreens Boots Alliance
WBA
$3.58M 2%
+99,603
New +$3.89M
IVZ icon
20
Invesco
IVZ
$13.6B
$3.56M 1.99%
312,031
-48,654
-13% -$516K
NTAP icon
21
NetApp
NTAP
$35.9B
$3.52M 1.97%
80,327
-13,067
-14% -$570K
CSCO icon
22
Cisco
CSCO
$457B
$3.4M 1.9%
86,298
-17,809
-17% -$776K
GM icon
23
General Motors
GM
$79.3B
$3.19M 1.79%
107,869
-22,686
-17% -$637K
HPQ icon
24
HP
HPQ
$24.8B
$3.12M 1.75%
164,254
-34,034
-17% -$621K
EOG icon
25
EOG Resources
EOG
$77.6B
$3.04M 1.71%
84,701
+51,668
+156% +$2.32M

Similar funds

Palouse Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Palouse Capital Management held 86 positions worth $179M, down 5.7% from $189M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Palouse Capital Management withdrew a net $13.9M in Q3 2020, closing 9 positions and reducing 50 holdings. Its most notable exit was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $6.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Financials.

Against the trend, Palouse Capital Management opened a new position in Vanguard Short-Term Corporate Bond ETF worth $6.21M.

  • Palouse Capital Management's largest Q3 2020 buy was Vanguard Short-Term Corporate Bond ETF: 75,017 shares worth $6.21M.
  • Palouse Capital Management added most to EOG Resources in Q3 2020, an estimated $2.32M increase.
  • Palouse Capital Management's biggest Q3 2020 reduction was FedEx, cutting an estimated $2.88M.
  • Palouse Capital Management fully exited PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q3 2020, selling an estimated $6.2M.
  • Palouse Capital Management's ten largest holdings make up 28% of its $179M portfolio in Q3 2020.
  • Palouse Capital Management opened 13 new positions and closed 9 in Q3 2020.
  • Palouse Capital Management's portfolio value fell 5.7% quarter-over-quarter to $179M.

Based on Palouse Capital Management's 13F filing for Q3 2020, filed 2 Nov 2020.